WO2000057729A3 - Boissons pour le traitement de troubles du metabolisme dus au glucose - Google Patents

Boissons pour le traitement de troubles du metabolisme dus au glucose Download PDF

Info

Publication number
WO2000057729A3
WO2000057729A3 PCT/US2000/007908 US0007908W WO0057729A3 WO 2000057729 A3 WO2000057729 A3 WO 2000057729A3 US 0007908 W US0007908 W US 0007908W WO 0057729 A3 WO0057729 A3 WO 0057729A3
Authority
WO
WIPO (PCT)
Prior art keywords
beverages
treatment
glucose metabolism
metabolism disorders
compositions
Prior art date
Application number
PCT/US2000/007908
Other languages
English (en)
Other versions
WO2000057729A2 (fr
Inventor
John D Mendlein
Janice E Thompson
Stuart A Fine
Kevin J Kinsella
Original Assignee
Akesis Pharm Inc
John D Mendlein
Janice E Thompson
Stuart A Fine
Kevin J Kinsella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akesis Pharm Inc, John D Mendlein, Janice E Thompson, Stuart A Fine, Kevin J Kinsella filed Critical Akesis Pharm Inc
Priority to AU43265/00A priority Critical patent/AU4326500A/en
Publication of WO2000057729A2 publication Critical patent/WO2000057729A2/fr
Publication of WO2000057729A3 publication Critical patent/WO2000057729A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions et des méthodes à la fois pour le traitement du diabète et pour le traitement des troubles du métabolisme dus au glucose. Ces compositions peuvent contenir une ou plusieurs sources biodisponibles de chrome et de vanadium, et peuvent se trouver sous forme de boissons liquides, ou de poudres ou de concentrés permettant de préparer ces boissons.
PCT/US2000/007908 1999-03-26 2000-03-24 Boissons pour le traitement de troubles du metabolisme dus au glucose WO2000057729A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU43265/00A AU4326500A (en) 1999-03-26 2000-03-24 Beverages for treatment of glucose metabolism disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12648899P 1999-03-26 1999-03-26
US60/126,488 1999-03-26
US12696099P 1999-03-30 1999-03-30
US60/126,960 1999-03-30

Publications (2)

Publication Number Publication Date
WO2000057729A2 WO2000057729A2 (fr) 2000-10-05
WO2000057729A3 true WO2000057729A3 (fr) 2001-02-08

Family

ID=26824709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/007908 WO2000057729A2 (fr) 1999-03-26 2000-03-24 Boissons pour le traitement de troubles du metabolisme dus au glucose

Country Status (2)

Country Link
AU (1) AU4326500A (fr)
WO (1) WO2000057729A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1011660A1 (fr) 1997-07-14 2000-06-28 Inter-Health Nutraceuticals Incorporated Compositions d'acide hydroxycitrique, complements alimentaires et pharmaceutiques et produits alimentaires fabriques a partir de ces compositions, et procede d'utilisation de tels produits pour la reduction du poids corporel
WO2002036202A2 (fr) * 2000-11-02 2002-05-10 Nutrition 21, Inc. Procedes et compositions permettant d'ameliorer la sensibilite insulinique, de reduire l'hyperglycemie, et de reduire l'hypercholesterolemie a l'aide de complexes de chrome et d'acide alphalipoique
US7119110B2 (en) * 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
US20030119913A1 (en) 2001-12-20 2003-06-26 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
EP1537865A1 (fr) * 2003-12-03 2005-06-08 Franz-Peter Dr. Liebel Utilisation de composés contenant du soufre et d'enzymes protéolytiques pour la prévention et la thérapie du Diabètes mellitus type II déficitaire de UDP-Glucuronosyltransférase 1
NL1037643C2 (en) * 2010-01-22 2011-07-25 Karel Paul Bouter Nutritional product comprising a biguanide.
AU2016250911A1 (en) * 2015-04-23 2017-11-09 Omniblend Innovation Pty Ltd Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile
JP6861708B2 (ja) * 2015-12-30 2021-04-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 除脂肪体重を測定するための方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5294606A (en) * 1992-11-24 1994-03-15 Reliv' International Inc. Isotonic energy composition and method to use same
US5480657A (en) * 1993-10-27 1996-01-02 Allen; Ann De Wees T. Composition comprising caffeine chromium and fructose for weight control and use thereof
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5294606A (en) * 1992-11-24 1994-03-15 Reliv' International Inc. Isotonic energy composition and method to use same
US5480657A (en) * 1993-10-27 1996-01-02 Allen; Ann De Wees T. Composition comprising caffeine chromium and fructose for weight control and use thereof
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics

Also Published As

Publication number Publication date
AU4326500A (en) 2000-10-16
WO2000057729A2 (fr) 2000-10-05

Similar Documents

Publication Publication Date Title
WO2000015211A3 (fr) Compositions et traitements contre les troubles du metabolisme du glucose
NZ504258A (en) Exendin 3 and 4 agonist compounds for the treatment of diabetes
AU1516301A (en) Use of a milk protein hydrolysate in the treatment of diabetes
ZA200110099B (en) Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same.
AU2002327430A1 (en) Methods for treating diabetes and other blood sugar disorders
WO2001046830A8 (fr) Transactions d'affaires utilisant l'internet
AU2001262153A1 (en) Pyrrole-2,5-dione derivatives for the treatment of diabetes
AU2002210991A1 (en) Novel glucose dehydrogenase and process for producing the dehydrogenase
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU2001247788A1 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
AU4871797A (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
WO1999011252A3 (fr) Chlorure de n,n-bis (phenylcarbamoylmethyl) dimethylammonium et ses derives, servant au traitement de la douleur
AU5844300A (en) Eugenia jambolina fruit extracts for treating diabetes
AU2984000A (en) Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
AU1873599A (en) Stent for implantation in the human body, especially in blood vessels
AU2158601A (en) Antiviral agent for use in treatment of cancer
WO2000057729A3 (fr) Boissons pour le traitement de troubles du metabolisme dus au glucose
PL353069A1 (en) Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
WO2000057721A3 (fr) Solides comestibles utilises dans le traitement des troubles du metabolisme glucosique
WO1999042139A3 (fr) Conjugues d'amidon hydroxyethyle, leur procede de production et produits pharmaceutiques les contenant
WO1997026918A3 (fr) Therapie par promedicament a enzyme dirige par ligand
AU7032700A (en) Low potassium juice, method for producing thereof and food containing the same
AU6908700A (en) Soft, absorbent material for use in absorbent articles and process for making the same
GB0210357D0 (en) Methods for regulating blood glucose and appetite suppression in type 2 diabetics
AU5914600A (en) Juice enriched in beneficial compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO COMMUNICATION, FORM 1205 ON :04.04.2003)

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase